Buy 3 AI-Powered Medical Stocks to Strengthen Your Portfolio in Q4
AI adoption is reshaping medical devices, with ISRG, TEM and TMO leveraging AI to advance precision medicine and drug development.
Zacks Investment Research9/24/2026Positive
ISRG
Intuitive Surgical IncNASDAQHEALTHCAREMEDICAL INSTRUMENTS & SUPPLIES
Key Statistics
Market Cap
$145.17B
P/E Ratio
46.52
EPS
$8.71
Beta
1.47
52W High
$603.88
52W Low
$328.57
50-Day MA
$373.87
200-Day MA
$451.71
Dividend Yield
—
Profit Margin
28.40%
Forward P/E
33.33
PEG Ratio
1.87
About Intuitive Surgical Inc
Intuitive Surgical, Inc. is an American corporation that develops, manufactures, and markets robotic products designed to improve clinical outcomes of patients through minimally invasive surgery, most notably with the da Vinci Surgical System.
Fundamentals
| Revenue (TTM) | $11.03B |
| Gross Profit (TTM) | $7.36B |
| EBITDA | $4.18B |
| Operating Margin | 33.60% |
| Return on Equity | 17.40% |
| Return on Assets | 10.50% |
| Revenue/Share (TTM) | $31.07 |
| Book Value | $51.34 |
| Price-to-Book | 7.82 |
| Price-to-Sales (TTM) | 13.16 |
| EV/Revenue | 12.4 |
| EV/EBITDA | 32.23 |
| Quarterly Earnings Growth (YoY) | 26.50% |
| Quarterly Revenue Growth (YoY) | 18.50% |
| Shares Outstanding | $358.28M |
| Float | $351.21M |
| % Insiders | 0.51% |
| % Institutions | 89.48% |
Historical Volatility
HV 10-Day
18.75%
HV 20-Day
27.59%
HV 30-Day
30.89%
HV 60-Day
49.85%
HV Rank
44.8%
Volatility is currently contracting
Analyst Ratings
Consensus ($476.34 target)
7
Strong Buy17
Buy8
Hold1
SellLatest News
Intuitive Surgical vs. Stryker: Which MedTech Stock Is the Better Buy Now?
ISRG's rapid procedure growth, expanding robotics ecosystem and recurring revenues highlight its growth path amid MedTech shifts.
Zacks Investment Research9/23/2026Positive
Ambulatory Surgery Centers Are Becoming ISRG's New Growth Engine
Intuitive Surgical is expanding robotic surgery in ASCs with lower-cost XiR systems, opening access to new customers and outpatient procedures.
Zacks Investment Research9/21/2026Positive
ISRG Wins EU Nod to Expand da Vinci SP in Gynecologic Procedures
Intuitive Surgical's CE mark expands da Vinci SP into transvaginal gynecology in Europe, opening a new women's health opportunity and growth runway.
Zacks Investment Research9/16/2026Positive
Intuitive Surgical, Inc. (ISRG) is Attracting Investor Attention: Here is What You Should Know
Recently, Zacks.com users have been paying close attention to Intuitive Surgical (ISRG). This makes it worthwhile to examine what the stock has in store.
Zacks Investment Research9/16/2026Positive
ISRG's da Vinci Study Shows Better Outcomes Across 13 Common Conditions
Intuitive Surgical's da Vinci meta-analysis across 14 million procedures found better perioperative outcomes versus laparoscopic and open surgery.
Zacks Investment Research9/15/2026Neutral
Can AI Keep ISRG Ahead of Rising Robotic Surgery Competition?
ISRG is using AI, software, data and advanced instruments to strengthen da Vinci 5 and stay ahead as robotic surgery competition intensifies.
Zacks Investment Research9/14/2026Positive
Intuitive Surgical Sees Procedure Growth Despite U.S. Slowdown and China Pressure
Intuitive Surgical NASDAQ: ISRG executives said the company remains focused on global procedure growth, while acknowledging a recent deceleration in U.S. procedures and policy-related uncertainty affecting hospitals.
MarketBeat9/11/2026Negative
This AI ETF Is Missing the Biggest AI Winners
For investors who favor exchange-traded funds (ETFs), the market has never been more dynamic. Not only do ETFs now outnumber individual stocks, but the sheer versatility of today's funds allows investors to target nuanced strategies, from exposure to thematic trends like the memory chip shortage to increasingly risky leveraged short-term speculation.
MarketBeat9/11/2026Neutral
Intuitive Surgical, Inc. (ISRG) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
Intuitive Surgical, Inc. (ISRG) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
Seeking Alpha9/9/2026Neutral
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on ISRG and any ticker you trade — then tracks every position and per-strategy win rate.
More HEALTHCARE Stocks
Data last updated: 9/28/2026